HERON THERAPEUTICS, INC. short interest in 2026
In 2026, HERON THERAPEUTICS, INC.'s disclosed short interest ran from 19.35% of shares outstanding on 15 Jan 2026 to 22.85% on 15 Sep 2026, a change of +3.50 percentage points. The year's high was 24.62% on 14 Aug 2026 and its low 18.76% on 13 Feb 2026, averaging 21.36% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 36.42 days on 30 Jan 2026. Full history: HERON THERAPEUTICS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 19.35% (15 Jan 2026)
- End of year
- 22.85% (15 Sep 2026)
- Change
- +3.50 pp
- High
- 24.62% (14 Aug 2026)
- Low
- 18.76% (13 Feb 2026)
- Average
- 21.36%
- Highest days to cover
- 36.42 (30 Jan 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 19.35% | 15.67 | |
| 30 Jan 2026 | 19.23% | 36.42 | |
| 13 Feb 2026 | 18.76% | 34.33 | |
| 27 Feb 2026 | 19.70% | 16.51 | 10-K filed, results (8-K) |
| 13 Mar 2026 | 19.53% | 19.37 | |
| 31 Mar 2026 | 20.91% | 18.36 | |
| 15 Apr 2026 | 21.83% | 26.81 | |
| 30 Apr 2026 | 21.68% | 17.80 | |
| 15 May 2026 | 20.96% | 14.04 | 10-Q filed, results (8-K) |
| 29 May 2026 | 21.22% | 23.68 | |
| 15 Jun 2026 | 22.12% | 6.70 | |
| 30 Jun 2026 | 21.40% | 11.12 | |
| 15 Jul 2026 | 22.52% | 13.35 | |
| 31 Jul 2026 | 22.85% | 24.44 | |
| 14 Aug 2026 | 24.62% | 12.33 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 23.63% | 18.54 | |
| 15 Sep 2026 | 22.85% | 27.84 |
See also: HERON THERAPEUTICS, INC.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.